SEER CIK: 1726445

Seer, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
412
FY22:
435
FY23:
331
FY24:
253
FY25:
202
(positive)
Change from FY21 to FY25
millions USD
FY21:
127
FY22:
52.9
FY23:
106
FY24:
113
FY25:
94.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
539
FY22:
488
FY23:
436
FY24:
367
FY25:
296

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
13.4
FY22:
12.6
FY23:
13.2
FY24:
15.3
FY25:
15.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
22.8
FY22:
28.4
FY23:
26.1
FY24:
23.7
FY25:
21.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
503
FY22:
447
FY23:
397
FY24:
328
FY25:
259
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
539
FY22:
488
FY23:
436
FY24:
367
FY25:
296

All amounts in millions USD Data source:SEC EDGAR